Tang Q, Shang F H, Wang X C, et al. Combination use of ferulic acid, ligustrazine and tetrahydropalmatine inhibits the growth of ectopic endometrial tissue:a multi-target therapy for endometriosis rats [J]. J Ethnopharmacol, 2014, 151 (3):1218.
Yan J J, He X, Feng S, et al. Up-regulation on cytochromes P450 in rat mediated by total alkaloid extract from Corydalis yanhusuo[J]. BMC Complement Altern Med, 2014, 14 (1):306.
[9]
Liu, X, Li H, Wu L, et al. Simultaneous quantification of chrysophanol and physcion in rat plasma by ultra fast liquid chromatography-tandem mass spectrometry and application of the technique to comparative pharmacokinetic studies of Radix et Rhei Rhizoma extract alone and Dahuang Fuzi decoction [J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2014, doi:10.1016/j.jchromb.2014.11.025.
[10]
Yan R, Wang Y, Shen W J, et al. Comparative pharmacokinetics of dehydroevodiamine and coptisine in rat plasma after oral administration of single herbs and Zuojinwan prescription [J]. Fitoterapia, 2011, 82 (8):1152.
[11]
Zhang A H, Sun H, Yuan Y, et al. An in vivo analysis of the therapeutic and synergistic properties of Chinese medicinal formula Yin-Chen-Hao-Tang based on its active constituents [J]. Fitoterapia, 2011, 82 (8):1160.
[12]
Jiang B, Cai F, Gao S H, et al. Induction of cytochrome P450 3A by Shexiang Baoxin pill and its main components [J]. Chem Biol Interact, 2012, 195 (2):105.
Borkar R M, Bhandi M M, Dubey A P, et al. Plasma protein binding, pharmacokinetics, tissue distribution and CYP450 biotransformation studies of fidarestat by ultra high performance liquid chromatography-high resolution mass spectrometry [J]. J Pharm Biomed Anal, 2015, 102:386.
[16]
Brewer L, Williams D. Drug interactions that matter[J]. Medicine, 2012, 40 (7):371.
Koe X F, Lim E L, Seah T C, et al. Evaluation of in vitro cytochrome P450 induction and inhibition activity of deoxyelephantopin, a sesquiterpene lactone from Elephantopus scaber L. [J].Food Chem Toxicol, 2013, 60:98.
Zhao Y, Hellum B H, Liang A H, et al. The in vitro inhibition of human CYP1A2, CYP2D6 and CYP3A4 by tetrahydropalmatine, neferine and berberine [J]. Phytother Res, 2012, 26 (2):277.
[21]
Sun S Y, Wang Y Q, Li L P, et al. Stereoselective interaction between tetrahydropalmatine enantiomers and CYP enzymes in human liver microsomes [J]. Chirality, 2013, 25 (1):43.
[22]
Martignoni M, Groothuis G M, de Kanter R. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction [J]. Expert Opin Drug Metab Toxicol, 2006, 2 (6):875.
Mikstacka R, Rimando A M, Dutkiewicz Z, et al. Design, synthesis and evaluation of the inhibitory selectivity of novel trans-resveratrol analogues on human recombinant CYP1A1, CYP1A2 and CYP1B1 [J]. Bioorg Med Chem, 2012, 20 (17):5117.
[25]
Sun M, Tang Y, Ding T G, et al. Inhibitory effects of celastrol on rat liver cytochrome P450 1A2, 2C11, 2D6, 2E1 and 3A2 activity [J]. Fitoterapia, 2014, 92:1.
[26]
Usia T, Iwata H, Hiratsuka A, et al. CYP3A4 and CYP2D6 inhibitory activities of indonesian medicinal plants [J]. Phytomedicine, 2006, 13 (1/2):67.
[27]
Li L, Ye M, Bi K S, et al. Liquid chromatography-tandem mass spectrometry for the identification of L-tetrahydropalmatine metabolites in penicillium janthinellum and rats [J]. Biomed Chromatogr, 2006, 20 (1):95.
[28]
Wang C, Zhou J R, Wang S W, et al. Shotgun approach based comparative proteomic analysis of levo-tetrahydropalmatine-induced apoptosis in hepatocytes [J]. Toxicol Lett, 2010, 194 (1/2):8.
